• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Galnon Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759251

Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue properties More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Galnon, Inhibitor
Full Product Name
Galnon
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
678.83
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C40H46N4O6
SMILES
Cc1cc(=O)oc2cc(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3CCCCC3)NC(=O)OCC3c4ccccc4-c4ccccc34)ccc12
CAS Number
475115-35-6
Target & IC50
Galanin receptor
In Vitro
Galnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury[1]. Galnon, a GAL receptor agonist, may enhance osteoclastic bone resorption in OVX rats. Although galnon reduced bone volume, biomechanical testing revealed that bone of galnon-treated animals was mechanically superior per unit area. Taken together, galnon simultaneously improves the intrinsic quality of cortical bone whilst stimulating osteoclastic activity in the OVX rat model[2].

Structure of Galnon, inhibitor

Galnon Inhibitor – Cat# MBS5759251

Product References and Citations for Galnon, inhibitor

Sollenberg U, Bartfai T, Langel U. Galnon - A low-molecular weight ligand of the galanin receptors[J]. Neuropeptides, 2005, 39(3):161-163.
Sollenberg U, Bartfai T, Langel U. Galnon - A low-molecular weight ligand of the galanin receptors[J]. Neuropeptides, 2005, 39(3):161-163.
Mcgowan H W, Schuijers J A, Grills B L, et al. Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model.[J]. Journal of Musculoskeletal & Neuronal Interactions, 2014, 14(2):162.
Mcgowan H W, Schuijers J A, Grills B L, et al. Galnon, a galanin receptor agonist, improves intrinsic cortical bone tissue properties but exacerbates bone loss in an ovariectomised rat model.[J]. Journal of Musculoskeletal & Neuronal Interactions, 2014, 14(2):162.

Other Notes

Small volumes of Galnon, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Galnon purchase

MBS5759251 is an inhibitor targeting Galnon.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000